Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China

Authors

  • Rossella Porcheddu Freelance Journalist, JIDC Italy
  • Caterina Serra Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy
  • David Kelvin JIDC-Canada; Department of Microbiology and Immunology, Canadian Center for Vaccinology, Dalhousie University, Halifax, NS, Canada. International Institute of Infection and Immunity, Shantou, China
  • Nikki Kelvin JIDC-Canada, Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada
  • Salvatore Rubino Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy

DOI:

https://doi.org/10.3855/jidc.12600

Keywords:

Novel coronavirus COVID-19, outbreak, Italy, Case Fatality Rates, SARS-CoV-19

Abstract

As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease.

Downloads

Published

2020-02-29

How to Cite

1.
Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S (2020) Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries 14:125–128. doi: 10.3855/jidc.12600

Issue

Section

Coronavirus Pandemic